Contrast Medium
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study on the Risk of Allergy-like Reactions After Intra-arterial or Intra-venous Injection of the Marketed X-ray Contrast Medium Iopromid (NCT03622801) | Bayer | 2018-10-12 |
Track Contrast Medium automatically
Every clearance here is in the API, with alerts when new ones post.